Skip to content

13F-HR filed by First Light Asset Management, LLC

First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-16, with 62 holding rows worth $202,432,000.

Accession
0001387131-15-003446
Filed
2015-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 62 entries on the cover page, a total value of $202,432,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $202,432,000 with VALUE read as thousands by filing date, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ATRICURE INC04963C209COM899,362$19,705,000thousands by filing date
NEOGENOMICS INC64049M209COM NEW2,971,545$17,027,000thousands by filing date
RTI BIOLOGICS INC74975N105COM1,996,191$11,338,000thousands by filing date
AKORN INC009728106COM324,480$9,249,000thousands by filing date
TEARLAB CORP878193101COM3,764,165$7,566,000thousands by filing date
HARVARD BIOSCIENCE INC416906105COM1,982,194$7,493,000thousands by filing date
Enzo Biochem Inc294100102Common Stock2,226,001$7,056,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS520,755$7,030,000thousands by filing date
LHC GROUP50187A107COM152,441$6,825,000thousands by filing date
IGI LABORATORIES INC449575109COM1,011,217$6,613,000thousands by filing date
OMNICELL COM COM68213N109Stock172,429$5,363,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock272,393$5,058,000thousands by filing date
BIO-TECHNE CORP09073M104COM54,286$5,019,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW57,571$4,931,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR302,194$4,886,000thousands by filing date
PHYSICIANS REALTY TRUST71943U104COM321,979$4,859,000thousands by filing date
LEMAITRE VASCULAR INC525558201COM376,211$4,586,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock988,589$4,508,000thousands by filing date
ENTELLUS MED INC29363K105COM242,532$4,370,000thousands by filing date
QUIDEL CORP74838J101COM201,067$3,796,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK240,229$3,788,000thousands by filing date
ALKERMES PLCG01767105SHS64,148$3,764,000thousands by filing date
ANGIODYNAMICS INC03475V101COM277,323$3,658,000thousands by filing date
SPECTRANETICS CORP84760C107COM285,596$3,367,000thousands by filing date
MEDICINES CO584688105COM84,103$3,193,000thousands by filing date
CEPHEID15670R107COM64,271$2,905,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM1,255,148$2,874,000thousands by filing date
ARROWHEAD RESEARCH CORP042797209COM465,503$2,681,000thousands by filing date
VERACYTE INC COM92337F107Stock564,932$2,650,000thousands by filing date
HEALTHSTREAM INC42222N103COM118,352$2,581,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM24,643$2,566,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM215,137$2,268,000thousands by filing date
ENDOLOGIX INC29266S106COM180,963$2,219,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM19,153$2,017,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM154,710$1,629,000thousands by filing date
BLUEBIRD BIO INC09609G100COM13,623$1,165,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock47,965$1,131,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM82,911$701,000thousands by filing date
HUMANA INC COM444859102Stock3,540$634,000thousands by filing date
Elevance Health, Inc.036752103COM4,095$573,000thousands by filing date
AETNA INC NEW00817Y108COM5,215$571,000thousands by filing date
ENDO INTL PLCG30401106SHS8,161$565,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR6,070$558,000thousands by filing date
ALLERGAN PLCG0177J108SHS2,035$553,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock3,820$501,000thousands by filing date
Bristol-Myers Squibb Company110122108COM8,290$491,000thousands by filing date
CELGENE CORP151020104COM4,280$463,000thousands by filing date
Eli Lilly and Company532457108COM5,495$460,000thousands by filing date
BECTON DICKINSON & CO075887109COM3,395$450,000thousands by filing date
STERIS CORP859152100COMMON STOCK6,330$411,000thousands by filing date
MYLAN NVN59465109SHS EURO9,775$394,000thousands by filing date
ST JUDE MED INC790849103COM6,055$382,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR11,360$361,000thousands by filing date
Johnson & Johnson478160104COM3,820$357,000thousands by filing date
Pfizer Inc.717081103COM10,520$330,000thousands by filing date
Merck & Co.,Inc.58933Y105COM6,610$326,000thousands by filing date
Amgen Inc.031162100COM2,330$322,000thousands by filing date
MYRIAD GENETICS INC62855J104COM7,820$293,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR5,680$270,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK6,145$263,000thousands by filing date
SUNOPTA INC8676EP108COM50,230$244,000thousands by filing date
BIO RAD LABS INC090572207CL A1,675$225,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-15-003446this filing2015-11-16acceptance time not in the bulk data set